Literature DB >> 19578342

Alzheimer disease: hippocampal volume loss and Alzheimer disease progression.

Wiesje M van der Flier, Philip Scheltens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19578342     DOI： 10.1038/nrneurol.2009.94

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

Review 1.  ApoE genotype accounts for the vast majority of AD risk and AD pathology.

Authors:  Jacob Raber; Yadong Huang; J Wesson Ashford
Journal:  Neurobiol Aging       Date:  2004 May-Jun       Impact factor: 4.673

Review 2.  A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

Authors:  Josephine Barnes; Jonathan W Bartlett; Laura A van de Pol; Clement T Loy; Rachael I Scahill; Chris Frost; Paul Thompson; Nick C Fox
Journal:  Neurobiol Aging       Date:  2008-03-17       Impact factor: 4.673

3.  A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.

Authors:  N A Verwey; W M van der Flier; K Blennow; C Clark; S Sokolow; P P De Deyn; D Galasko; H Hampel; T Hartmann; E Kapaki; L Lannfelt; P D Mehta; L Parnetti; A Petzold; T Pirttila; L Saleh; A Skinningsrud; J C V Swieten; M M Verbeek; J Wiltfang; S Younkin; P Scheltens; M A Blankenstein
Journal:  Ann Clin Biochem       Date:  2009-04-02       Impact factor: 2.057

4.  Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Authors:  Annika Olsson; Hugo Vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

5.  Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Authors:  W J P Henneman; J D Sluimer; J Barnes; W M van der Flier; I C Sluimer; N C Fox; P Scheltens; H Vrenken; F Barkhof
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

6.  Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

Authors:  L A van de Pol; W M van der Flier; E S C Korf; N C Fox; F Barkhof; P Scheltens
Journal:  Neurology       Date:  2007-10-09       Impact factor: 9.910

7.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Authors:  Oskar Hansson; Henrik Zetterberg; Peder Buchhave; Elisabet Londos; Kaj Blennow; Lennart Minthon
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

8.  Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

Authors:  A E van der Vlies; E L G E Koedam; Y A L Pijnenburg; J W R Twisk; P Scheltens; W M van der Flier
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

9.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Authors:  N Schuff; N Woerner; L Boreta; T Kornfield; L M Shaw; J Q Trojanowski; P M Thompson; C R Jack; M W Weiner
Journal:  Brain       Date:  2009-02-27       Impact factor: 13.501
  9 in total
  9 in total

1.  Integration of white matter network is associated with interindividual differences in psychologically mediated placebo response in migraine patients.

Authors:  Jixin Liu; Shaohui Ma; Junya Mu; Tao Chen; Qing Xu; Wanghuan Dun; Jie Tian; Ming Zhang
Journal:  Hum Brain Mapp       Date:  2017-07-21       Impact factor: 5.038

2.  Memory and neurogenesis in aging and Alzheimer's disease.

Authors:  Jesus Avila; Ricardo Insausti; Joaquin Del Rio
Journal:  Aging Dis       Date:  2010-05-21       Impact factor: 6.745

3.  Common hippocampal structural and functional changes in migraine.

Authors:  Nasim Maleki; Lino Becerra; Jennifer Brawn; Bruce McEwen; Rami Burstein; David Borsook
Journal:  Brain Struct Funct       Date:  2012-07-04       Impact factor: 3.270

4.  Self-reported subjective cognitive decline is associated with global cognition in a community sample of Latinos/as/x living in the United States.

Authors:  Marina Z Nakhla; Lynn Cohen; David P Salmon; Denis S Smirnov; María J Marquine; Alison A Moore; Dawn M Schiehser; Zvinka Z Zlatar
Journal:  J Clin Exp Neuropsychol       Date:  2021-10-28       Impact factor: 2.475

Review 5.  Changing perspectives regarding late-life dementia.

Authors:  Majid Fotuhi; Vladimir Hachinski; Peter J Whitehouse
Journal:  Nat Rev Neurol       Date:  2009-11-17       Impact factor: 42.937

6.  A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder.

Authors:  Pan Guo; Shasha Chen; Hao Wang; Yaogang Wang; Ju Wang
Journal:  Front Aging Neurosci       Date:  2022-01-20       Impact factor: 5.750

7.  Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach.

Authors:  Hugo Alexandre Ferreira; Diana Prata; Vasco Sá Diogo
Journal:  Alzheimers Res Ther       Date:  2022-08-03       Impact factor: 8.823

8.  Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition.

Authors:  Michael W Marlatt; Jan Bauer; Eleonora Aronica; Elise S van Haastert; Jeroen J M Hoozemans; Marian Joels; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-19       Impact factor: 3.599

9.  APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

Authors:  Emily N Manning; Josephine Barnes; David M Cash; Jonathan W Bartlett; Kelvin K Leung; Sebastien Ourselin; Nick C Fox
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.